These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22304788)

  • 1. Activated leukocyte cell adhesion molecule is expressed in neuroepithelial neoplasms and decreases with tumor malignancy, matrix metalloproteinase 2 expression, and absence of IDH1R132H mutation.
    Allmendinger O; Trautmann K; Mittelbronn M; Waidelich J; Meyermann R; Tatagiba M; Schittenhelm J
    Hum Pathol; 2012 Aug; 43(8):1289-99. PubMed ID: 22304788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
    Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
    Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the IDH1 codon 132 mutation in brain tumors.
    Balss J; Meyer J; Mueller W; Korshunov A; Hartmann C; von Deimling A
    Acta Neuropathol; 2008 Dec; 116(6):597-602. PubMed ID: 18985363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.
    Hartmann C; Meyer J; Balss J; Capper D; Mueller W; Christians A; Felsberg J; Wolter M; Mawrin C; Wick W; Weller M; Herold-Mende C; Unterberg A; Jeuken JW; Wesseling P; Reifenberger G; von Deimling A
    Acta Neuropathol; 2009 Oct; 118(4):469-74. PubMed ID: 19554337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
    Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
    Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology.
    Capper D; Reuss D; Schittenhelm J; Hartmann C; Bremer J; Sahm F; Harter PN; Jeibmann A; von Deimling A
    Acta Neuropathol; 2011 Feb; 121(2):241-52. PubMed ID: 21069360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
    Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
    Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencing.
    Takano S; Tian W; Matsuda M; Yamamoto T; Ishikawa E; Kaneko MK; Yamazaki K; Kato Y; Matsumura A
    Brain Tumor Pathol; 2011 Apr; 28(2):115-23. PubMed ID: 21344322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin D and its prognostic value in neuroepithelial brain tumors.
    Pigac B; Dmitrović B; Marić S; Masić S
    Coll Antropol; 2012 Mar; 36(1):227-33. PubMed ID: 22816225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis of oligodendrogliomas expressing a mutant isocitrate dehydrogenase-1.
    Thirant C; Varlet P; Lipecka J; Le Gall M; Broussard C; Chafey P; Studler JM; Lacombe J; Lions S; Guillaudeau A; Camoin L; Daumas-Duport C; Junier MP; Chneiweiss H
    Proteomics; 2011 Nov; 11(21):4139-54. PubMed ID: 21898821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase activity and alterations in telomere length in human brain tumors.
    Hiraga S; Ohnishi T; Izumoto S; Miyahara E; Kanemura Y; Matsumura H; Arita N
    Cancer Res; 1998 May; 58(10):2117-25. PubMed ID: 9605755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hypermethylation of the O6-methylguanine-DNA methyltransferase gene promoter in gliomas--correlation with array comparative genome hybridization results and IDH1 mutation.
    Tuononen K; Tynninen O; Sarhadi VK; Tyybäkinoja A; Lindlöf M; Antikainen M; Näpänkangas J; Hirvonen A; Mäenpää H; Paetau A; Knuutila S
    Genes Chromosomes Cancer; 2012 Jan; 51(1):20-9. PubMed ID: 21922591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IDH1 mutation, a genetic alteration associated with adult gliomatosis cerebri.
    Narasimhaiah D; Miquel C; Verhamme E; Desclée P; Cosnard G; Godfraind C
    Neuropathology; 2012 Feb; 32(1):30-7. PubMed ID: 21481010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein D expression in primary brain tumors: analysis by quantitative RT-PCR in formalin-fixed, paraffin-embedded tissue.
    Hunter SB; Varma V; Shehata B; Nolen JD; Cohen C; Olson JJ; Ou CY
    J Histochem Cytochem; 2005 Aug; 53(8):963-9. PubMed ID: 16055749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of WT1 in neuroepithelial tumours.
    Schittenhelm J; Beschorner R; Simon P; Tabatabai G; Herrmann C; Schlaszus H; Capper D; Weller M; Meyermann R; Mittelbronn M
    Neuropathol Appl Neurobiol; 2009 Feb; 35(1):69-81. PubMed ID: 18466223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KPNA2 predicts long term survival in patients with anaplastic oligoastrocytomas.
    Gousias K; Niehusmann P; Gielen G; Simon M; Boström J
    J Clin Neurosci; 2014 Oct; 21(10):1719-24. PubMed ID: 24929863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of immunohistochemical expression analysis of metabolic-related molecules in differentiating between intracranial neoplastic and non-neoplastic lesions.
    Makino K; Nakamura H; Hide T; Yano S; Kuroda J; Takahashi Y; Iyama K; Kuratsu J
    Brain Tumor Pathol; 2013 Jul; 30(3):144-50. PubMed ID: 23064941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes.
    Seiz M; Tuettenberg J; Meyer J; Essig M; Schmieder K; Mawrin C; von Deimling A; Hartmann C
    Acta Neuropathol; 2010 Aug; 120(2):261-7. PubMed ID: 20514489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IDH1 mutation in pediatric gliomas: has it a diagnostic and prognostic value?
    Buccoliero AM; Castiglione F; Degl'Innocenti DR; Gheri CF; Genitori L; Taddei GL
    Fetal Pediatr Pathol; 2012 Oct; 31(5):278-82. PubMed ID: 22432788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of coronin-3 (coronin-1C) in diffuse gliomas is related to malignancy.
    Thal D; Xavier CP; Rosentreter A; Linder S; Friedrichs B; Waha A; Pietsch T; Stumpf M; Noegel A; Clemen C
    J Pathol; 2008 Mar; 214(4):415-24. PubMed ID: 18189330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.